Paradigm Biocapital Advisors as of Sept. 30, 2023
Portfolio Holdings for Paradigm Biocapital Advisors
Paradigm Biocapital Advisors holds 30 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Legend Biotech Corp Sponsored Ads (LEGN) | 9.2 | $136M | 2.0M | 67.17 | |
| Argenx Se Sponsored Adr (ARGX) | 8.7 | $129M | 261k | 491.63 | |
| Arcellx Common Stock (ACLX) | 7.2 | $106M | 3.0M | 35.88 | |
| Olema Pharmaceuticals (OLMA) | 6.5 | $96M | 7.8M | 12.35 | |
| Nuvalent Inc-a (NUVL) | 5.1 | $75M | 1.6M | 45.97 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 5.0 | $73M | 3.6M | 20.09 | |
| Mirati Therapeutics | 4.9 | $73M | 1.7M | 43.56 | |
| Immunocore Hldgs Ads (IMCR) | 4.9 | $72M | 1.4M | 51.90 | |
| United Therapeutics Corporation (UTHR) | 4.7 | $69M | 307k | 225.87 | |
| Crinetics Pharmaceuticals In (CRNX) | 4.4 | $65M | 2.2M | 29.74 | |
| Disc Medicine (IRON) | 4.1 | $60M | 1.3M | 46.98 | |
| Miragen Therapeutics (VRDN) | 3.8 | $57M | 3.7M | 15.34 | |
| Cerevel Therapeutics Hldng I (CERE) | 3.8 | $55M | 2.5M | 21.83 | |
| Incyte Corporation (INCY) | 3.6 | $53M | 913k | 57.77 | |
| Xenon Pharmaceuticals (XENE) | 3.5 | $51M | 1.5M | 34.16 | |
| Ambrx Biopharma Sponsored Ads Call Option | 2.9 | $43M | 3.7M | 11.50 | |
| Syndax Pharmaceuticals (SNDX) | 2.4 | $35M | 2.4M | 14.52 | |
| Autolus Therapeutics Spon Ads (AUTL) | 2.3 | $34M | 14M | 2.33 | |
| Tg Therapeutics (TGTX) | 2.1 | $30M | 3.6M | 8.36 | |
| Zai Lab Adr (ZLAB) | 1.9 | $28M | 1.1M | 24.31 | |
| Alpine Immune Sciences (ALPN) | 1.9 | $28M | 2.4M | 11.45 | |
| Immatics SHS (IMTX) | 1.6 | $24M | 2.1M | 11.58 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.0 | $15M | 926k | 16.30 | |
| Caribou Biosciences (CRBU) | 1.0 | $14M | 2.9M | 4.78 | |
| Vor Biopharma (VOR) | 0.9 | $14M | 6.5M | 2.12 | |
| Roivant Sciences SHS (ROIV) | 0.9 | $13M | 1.1M | 11.68 | |
| Kura Oncology (KURA) | 0.8 | $11M | 1.2M | 9.12 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.7 | $10M | 1.4M | 7.40 | |
| 89bio Call Option (ETNB) | 0.3 | $5.1M | 329k | 15.44 | |
| Cogent Biosciences (COGT) | 0.1 | $2.2M | 226k | 9.75 |
